RecruitingNot ApplicableNCT05807178

Stabilization of Circadian Rhythms in Delirious ICU Patients Through Light Intervention


Sponsor

Charite University, Berlin, Germany

Enrollment

40 participants

Start Date

Jan 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators will examine the effects of dynamic light therapy on circadian rhythms in delirious intensive care unit (ICU) patients. In a randomized controlled trial (RCT), they will investigate the effects of a specific light algorithm on rhythms of serum melatonin, clock gene expression, the proteome, and metabolome, compared to standard hospital lighting, supported by the data science algorithms to improve vital-based algorithms with light interventions.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Dynamic Light Therapy Device, LSA-1 and Dynamic Light Therapy Device, LSA-2 for people with circadian dysrhythmia. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDynamic Light Therapy Device, LSA-1

Dynamic Light Therapy

DEVICEDynamic Light Therapy Device, LSA-2

Light Exposition


Locations(2)

Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Campus Charité Mitte

Berlin, Germany

Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Campus Virchow Klinikum

Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05807178


Related Trials